Modeling Parkinson's Disease in Zebrafish

被引:16
|
作者
Najib, Nor H. M. [1 ]
Nies, Yong H. [1 ]
Abd Halim, Syarifah A. S. [1 ]
Yahaya, Mohamad F. [1 ]
Das, Srijit [1 ]
Lim, Wei L. [2 ]
Teoh, Seong L. [1 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Anat, Med Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Sunway Univ, Sch Sci & Technol, Dept Biol Sci, Subang Jaya, Selangor, Malaysia
关键词
Neurodegenerative disease; disease models; neurotoxins; transgenic; Danio rerio; Parkinson's Disease (PD); BLOOD-BRAIN-BARRIER; ALPHA-SYNUCLEIN; CELL-DEATH; MICROGLIAL ACTIVATION; NONMOTOR SYMPTOMS; OXIDATIVE STRESS; ANIMAL-MODELS; DANIO-RERIO; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION;
D O I
10.2174/1871527319666200708124117
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's Disease (PD) is one of the most common neurodegenerative disorders that affects the motor system, and includes cardinal motor symptoms such as resting tremor, cogwheel rigidity, bradykinesia and postural instability. Its prevalence is increasing worldwide due to the increase in life span. Although, two centuries since the first description of the disease, no proper cure with regard to treatment strategies and control of symptoms could be reached. One of the major challenges faced by the researchers is to have a suitable research model. Rodents are the most common PD models used, but no single model can replicate the true nature of PD. In this review, we aim to discuss another animal model, the zebrafish (Danio rerio), which is gaining popularity. Zebrafish brain has all the major structures found in the mammalian brain, with neurotransmitter systems, and it also possesses a functional blood-brain barrier similar to humans. From the perspective of PD research, the zebrafish possesses the ventral diencephalon, which is thought to be homologous to the mammalian substantia nigra. We summarize the various zebrafish models available to study PD, namely chemical-induced and genetic models. The zebrafish can complement the use of other animal models for the mechanistic study of PD and help in the screening of new potential therapeutic compounds.
引用
收藏
页码:386 / 399
页数:14
相关论文
共 50 条
  • [1] Screening Zebrafish for Parkinson’s disease drugs
    Alexandra Le Bras
    [J]. Lab Animal, 2021, 50 : 310 - 310
  • [2] Screening Zebrafish for Parkinson's disease drugs
    Le Bras, Alexandra
    [J]. LAB ANIMAL, 2021, 50 (11) : 310 - 310
  • [3] Modeling Parkinson's Disease
    Olanow, C. Warren
    Kordower, Jeffrey H.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 (04) : 432 - 436
  • [4] ZEBRAFISH MODELS FOR EARLY ONSET PARKINSON'S DISEASE
    Bandmann, O.
    Flinn, L.
    Mortiboys, H.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (11): : E59 - E59
  • [5] A Critical Review of Zebrafish Models of Parkinson's Disease
    Doyle, Jillian M.
    Croll, Roger P.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Studying the Pathophysiology of Parkinson's Disease Using Zebrafish
    Barnhill, Lisa M.
    Murata, Hiromi
    Bronstein, Jeff M.
    [J]. BIOMEDICINES, 2020, 8 (07)
  • [7] Development of a MPTP model of Parkinson's disease in zebrafish
    Salzmann, J.
    Anichtchik, O.
    Best, J.
    Richards, F.
    Fleming, A.
    Roach, A.
    Goldsmith, P.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2006, 17 (5-6): : 541 - 541
  • [8] Modeling anxiety in Parkinson's disease
    Broen, Martijn P. G.
    Kohler, Sebastian
    Moonen, Anja J. H.
    Kuijf, Mark L.
    Dujardin, Kathy
    Marsh, Laura
    Richard, Irene H.
    Starkstein, Sergio E.
    Martinez-Martin, Pablo
    Leentjens, Albert F. G.
    [J]. MOVEMENT DISORDERS, 2016, 31 (03) : 310 - 316
  • [9] PARKINSON'S DISEASE MODELING ANALYSIS
    Mikliev, Z.
    Safarova, S.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E92 - E92